Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...

WeightWatchers has filed for bankruptcy in the US amid surging demand for weight-loss drugs like Ozempic and Mounjaro ... an all-time low amid dwindling sales. The situation worsened when ...

The launch of Mounjaro always raised the risk that it would cannibalise sales of Lilly's own GLP-1 agonist Trulicity (dulaglutide), which is competing head-to-head with Ozempic in the market, but ...

A MOTHER has revealed that she lost over seven stone after using Ozempic for 12 months. Hannah, who is from the United States ... who died after taking Mounjaro, another weight loss injection ...

Analysts on average expect Novo to make 132.1 billion Danish crowns ($20.1 billion) from Ozempic sales and $97.23 billion crowns ($14.79 billion)from sales of Wegovy this year, according to LSEG data.

Revenues of $12.73 billion rose 45% year over year driven by strong sales of Lilly’s popular tirzepatide medicines, diabetes drug Mounjaro ... dynamics in the United States and currency ...

Mounjaro is another injectable ... approach to weight loss. Recently, Ozempic has become popular for weight loss use, and as a result, the United States has been experiencing a shortage.

Former speed skater Sarah Lindsay believes injections such as Ozempic and Mounjaro — known as GLP-1 drugs — are leaving users malnourished and vitamin-deficient. The 44-year-old celebrity ...